Literature DB >> 21167195

Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats.

Tomáš Páleníček1, Marie Balíková, Miroslava Rohanová, Tomáš Novák, Jiří Horáček, Michaela Fujáková, Cyril Höschl.   

Abstract

Despite poisoning with the ecstasy substitute para-methoxymethamphetamine (PMMA) being typically associated with severe hyperthermia and death, behavioral and toxicological data on this drug are missing. Herein we present the behavioral profile of PMMA, its hyperthermic potency and pharmacokinetic profile in rats. The effects of PMMA 5 and 20 mg/kg on locomotion, on prepulse inhibition (PPI) of acoustic startle reaction (ASR), on body temperature under isolated and crowded conditions and on the pharmacokinetics analyzed with gas chromatography mass spectrometry (GC-MS) were evaluated. PMMA increased overall locomotion with the higher dose showing a biphasic effect. PPI was decreased dose-dependently. The hyperthermic response was present only with PMMA 20 mg/kg and was accompanied by extensive perspiration under crowded conditions. Serum levels of PMMA peaked at approximately 30 min after both treatments; on the contrary the maximum brain concentrations of PMMA at 20 mg/kg peaked approximately 1h after the administration, which was rather delayed compared to maximum after 5mg/kg dose. These data indicate that PMMA has a similar behavioral profile to stimulants and hallucinogens and that the toxicity might be increased in a crowded environment. High doses of PMMA have a gradual penetration to the brain which might lead to the delayed peak concentrations and prolonged effects of the drug.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167195     DOI: 10.1016/j.pbb.2010.12.011

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case series.

Authors:  Jennifer J E Nicol; Mark C Yarema; Graham R Jones; Walter Martz; Roy A Purssell; Judy C MacDonald; Ian Wishart; Monica Durigon; Despina Tzemis; Jane A Buxton
Journal:  CMAJ Open       Date:  2015-01-13

2.  Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.

Authors:  Tibor M Brunt; Maarten W Koeter; Raymond J M Niesink; Wim van den Brink
Journal:  Psychopharmacology (Berl)       Date:  2011-10-13       Impact factor: 4.530

3.  Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.

Authors:  Tomáš Páleníček; Michaela Fujáková; Martin Brunovský; Jiří Horáček; Ingmar Gorman; Marie Balíková; Lukáš Rambousek; Kamila Syslová; Petr Kačer; Petr Zach; Věra Bubeníková-Valešová; Filip Tylš; Anna Kubešová; Jana Puskarčíková; Cyril Höschl
Journal:  Psychopharmacology (Berl)       Date:  2012-07-29       Impact factor: 4.530

4.  Evaluation of the behavioral and pharmacokinetic profile of SYA013, a homopiperazine analog of haloperidol in rats.

Authors:  Barbara Bricker; Tanise Jackson; Bernard Boateng; Xue Y Zhu; Seth Y Ablordeppey
Journal:  Pharmacol Biochem Behav       Date:  2012-05-12       Impact factor: 3.533

5.  Evaluation of SYA16263 as a new potential antipsychotic agent without catalepsy.

Authors:  Barbara A Bricker; Kwame Peprah; Hye J Kang; S Y Ablordeppey
Journal:  Pharmacol Biochem Behav       Date:  2019-02-12       Impact factor: 3.533

6.  Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats.

Authors:  Kristýna Štefková; Monika Židková; Rachel R Horsley; Nikola Pinterová; Klára Šíchová; Libor Uttl; Marie Balíková; Hynek Danda; Martin Kuchař; Tomáš Páleníček
Journal:  Front Psychiatry       Date:  2017-11-17       Impact factor: 4.157

7.  Behavioural, Pharmacokinetic, Metabolic, and Hyperthermic Profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the Wistar Rat.

Authors:  Rachel R Horsley; Eva Lhotkova; Katerina Hajkova; Barbara Feriancikova; Michal Himl; Martin Kuchar; Tomas Páleníček
Journal:  Front Psychiatry       Date:  2018-04-24       Impact factor: 4.157

8.  Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats.

Authors:  Klára Šíchová; Nikola Pinterová; Monika Židková; Rachel R Horsley; Eva Lhotková; Kristýna Štefková; Čestmír Vejmola; Libor Uttl; Marie Balíková; Martin Kuchař; Tomáš Páleníček
Journal:  Front Psychiatry       Date:  2018-01-10       Impact factor: 4.157

Review 9.  Synthetic Aminoindanes: A Summary of Existing Knowledge.

Authors:  Nikola Pinterova; Rachel R Horsley; Tomas Palenicek
Journal:  Front Psychiatry       Date:  2017-11-17       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.